Home Alzheimer’s Disease Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19

Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19

In an editorial, researchers from the Society for Immunotherapy of Cancer (SITC) suggested that though definitive data showing that IL-6 receptor blockade benefits patients with COVID-19 induced pneumonitis are currently lacking, an effort should be made to maximize the availability of anti-IL-6 agents on a compassionate basis to treat hospitalized critically ill patients infected with COVID-19.

Further, they suggested that considerations should be given to focus efforts on rapidly expanding the ability of clinicians and clinical investigators to access investigational anti-IL-6 agents, particularly for agents where phase I and/or phase II studies have been completed and acceptable safety was demonstrated.

“Even if the primary impact of a single dose of these drugs is to accelerate recovery and get patients off ventilator support and out of the ICU more rapidly, this could…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

My Brain Tumor Taught Me To Shift My Perspective on These 5 Things

submitted by /u/andrewjoegeorge Continue Reading to the Source

Recent Comments